Local scientists are now able to study cancer using the first-of-its-kind TESCAN Q-Phase microscope.
Doctors at Mayo Clinic said the TESCAN Q-Phase offers rapid clarity on whether or not trail treatments are destroying cancer cells.
That really helps to be able to pinpoint what type of treatments will and will not work.
Dr. Maarten Rotman, Research Fellow, Mayo Clinic
Maarten explained that by using the holographic microscope, he can see cancer cells explode in real time.
This microscope allows us to really see how single cells even in clumps of different cells are able to divide or migrate and respond to treatments that we give them which are ways we try to kill brain cancer cells.
Dr. Maarten Rotman, Research Fellow, Mayo Clinic
The state-of-art technology is at the MSERF Laboratory of the University of North Florida (UNF) for 90 days.
Lab director Paul Eason said the practical experience offers the UNF students an advantage.
TESCAN USA, Inc.
Founded in 1991 by a group of managers and engineers from Tesla with its electron microscopy history starting in the 1950’s, today TESCAN is a globally renowned supplier of Focused Ion Beam workstations, Scanning Electron Microscopes and Optical Microscopes. TESCAN’s innovative solutions and collaborative nature with its customers have won it a leading position in the world of nano- and microtechnology. The company is proud to participate in premier research projects with prominent institutions across a range of scientific fields. TESCAN provides its clients with leading-class products in terms of value, quality and reliability. TESCAN USA, Inc. is the North American arm of TESCAN ORSAY HOLDINGS, a multinational company established by the merger of Czech company TESCAN, a leading global supplier of SEMs and Focused Ion Beam workstations, and the French company ORSAY PHYSICS, a world leader in customized Focused Ion Beam and Electron Beam technology.